Company news

EMV Capital PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Notice of Results and Investor Presentation

May 31, 2024

DeepTech Recycling: Fundraising, Business Update

May 31, 2024

Investment in Wanda, related party transactions

May 28, 2024

PDS Biotech: Business Update and Q1 2024 Results

May 15, 2024

Martlet Capital: mandate and acquisition

May 13, 2024

PDS Biotech: Clinical trial meets study endpoints

May 10, 2024

ProAxsis secures c.£1.8mn investment

April 15, 2024

PDS Strategy Update and 2023 Financial Results

March 27, 2024

Business Update

March 13, 2024

Exercise of Options and Issue of Shares

February 5, 2024

Glycotest secures $1 million investment

January 23, 2024

DeepTech Recycling secures £1 million investment

December 1, 2023

PDS BioTechnology: Third Quarter Results

November 14, 2023

PDS Biotech Announces Updated Survival Data

November 9, 2023

Ventive secures c.£900,000 investment

November 6, 2023

Change of Adviser

November 2, 2023

PDS Preliminary Biomarker Study Results

October 23, 2023

Exercise of Options

October 13, 2023

PDS: Interim 24-month survival rate of 74% update

October 3, 2023

PDS Biotech: new data on PDS0101

October 3, 2023

Q-Bot: £3.5 million investment to drive expansion

September 13, 2023

PDS Biotech: 2nd Quarter Results, Business Update

August 14, 2023

PDS Biotech: Submission of Phase 3 Protocol to FDA

August 14, 2023

Grant of Options, Issue of Shares, Director/PDMR

July 3, 2023

DName-iT Holdings Limited Fundraising

June 30, 2023

Result of AGM & Board Changes

June 29, 2023

Vortex Fundraising

June 22, 2023

PDS Announces Achievement of Efficacy Threshold

June 14, 2023

Preliminary Results for the year ended 31 Dec 2022

May 31, 2023

Board Changes

May 31, 2023

PDS Biotech Announces Interim Data

May 26, 2023

Sofant and Inmarsat announce joint development

May 24, 2023

PDS Business Update and First Quarter Results

May 15, 2023

Glycotest, Inc. Fundraising

May 2, 2023

PDS Update

March 30, 2023

PDS Business Update and 2022 Financial Results

March 28, 2023

Related party loan to ProAxsis Limited

February 28, 2023

PDS completes FDA meeting for triple combination

February 27, 2023

Second Price Monitoring Extn

February 10, 2023

Price Monitoring Extension

February 10, 2023

Board Change

February 1, 2023

PDS Announces Exclusive Global License Agreement

January 3, 2023

PDS Biotech: Median Overall Survival announcement

December 28, 2022

PDS: HPV16 Head and Neck Cancer announcement

December 16, 2022

Board Changes; Options; Co-Investment Agreement

December 12, 2022

EMV C leads £4.2m round in 5G and SATCOM leader

November 29, 2022

PDS Q3 Results and Business Update

November 14, 2022

PDS reports presentation of data at cancer society

November 7, 2022

EMV Capital secures investment in Ventive

October 20, 2022

PDS completes End-of-Phase 2 meeting with FDA

October 3, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 14 calls. Every call is listed under its year.

Decks

The 5 newest of 15 decks. Every deck is listed under its year.